4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000034
CEO bought 181,000 shares at an average $0.01 ($1,725)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-24 | Purchase : show line 1 in the form | +29,800 | $0.01 | $283 | 23,324,397 | D |
| 2019-05-24 | Purchase : show line 2 in the form | +20,200 | $0.01 | $190 | 23,344,597 | D |
| 2019-05-24 | Purchase : show line 3 in the form | +20,000 | $0.01 | $188 | 23,364,597 | D |
| 2019-05-24 | Purchase : show line 4 in the form | +10,000 | $0.01 | $100 | 23,374,597 | D |
| 2019-05-24 | Purchase : show line 5 in the form | +10,000 | $0.01 | $98 | 23,384,597 | D |
| 2019-05-24 | Purchase : show line 6 in the form | +20,000 | $0.01 | $192 | 23,404,597 | D |
| 2019-05-24 | Purchase : show line 7 in the form | +20,000 | $0.01 | $190 | 23,424,597 | D |
| 2019-05-24 | Purchase : show line 8 in the form | +1,000 | $0.01 | $10 | 23,425,597 | D |
| Open-market purchases · 181,000 sh · avg $0.01 · $1,725 | ||||||
Loading xslF345X03/primary_doc.xml…